Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression
Molecular profiling and the discovery of drugs that target specific activating mutations have allowed the personalization of treatment for non-small cell lung cancer (NSCLC). The epithelial growth factor receptor (EGFR) is frequently over-expressed and/or aberrantly activated in different cancers, i...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2016
|
| 在线阅读: | https://doi.org/10.1634/theoncologist.2016-0285 https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2016-0285 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|